Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.

MLA

Griffiths, Megan, et al. “Pediatric Pulmonary Hypertension: Insulin-like Growth Factor-Binding Protein 2 Is a Novel Marker Associated with Disease Severity and Survival.” Pediatric Research, vol. 88, no. 6, Dec. 2020, pp. 850–56. EBSCOhost, https://doi.org/10.1038/s41390-020-01113-x.

APA

Griffiths, M., Yang, J., Nies, M., Vaidya, D., Brandal, S., Williams, M., Matsui, E. C., Grant, T., Damico, R., Ivy, D., Austin, E. D., Nichols, W. C., Pauciulo, M. W., Lutz, K., Rosenzweig, E. B., Hirsch, R., Yung, D., & Everett, A. D. (2020). Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival. Pediatric Research, 88(6), 850–856. https://doi.org/10.1038/s41390-020-01113-x

Chicago

Griffiths, Megan, Jun Yang, Melanie Nies, Dhananjay Vaidya, Stephanie Brandal, Monica Williams, Elizabeth C Matsui, et al. 2020. “Pediatric Pulmonary Hypertension: Insulin-like Growth Factor-Binding Protein 2 Is a Novel Marker Associated with Disease Severity and Survival.” Pediatric Research 88 (6): 850–56. doi:10.1038/s41390-020-01113-x.